title: Hedgehog pathway aberrations and gastric cancer; evaluation of prognostic impact and exploration of therapeutic potentials.
abstract: Gastric cancer is an important cause for mortality and morbidity worldwide; it lies in the fourt rank as a cause of cancer-related death in males and in the fifth rank of cancer-related death in women. The prognosis of advanced/metastatic gastric cancer cases looks poor with the majority of available therapeutics. Thus, novel therapeutic strategies in this setting have been considered a priority for leading cooperative oncology groups. Hedgehog(Hh) pathway aberrations have sparked particular interest as prognostic markers with data from multiple studies showing consistent evidence of a poor prognostic value of Gli over expression in gastric cancer while on the other hand the prognostic significance of Hh protein over expression (particularly SHH) was not consistent among different studies. This review article revises the prognostic and potential therapeutic opportunities in the targeting of hedgehog pathway in gastric cancer.
authors: Clinical Oncology Department, Faculty of Medicine, Ain shams University, Cairo, Egypt, omar.abdelrhman@med.asu.edu.eg.
authors: Omar
authors: O
authors: Abdel-Rahman
mesh_terms: D000818:Animals; D000970:Antineoplastic Agents / Q000494:pharmacology* / Q000627:therapeutic use*; D053823:Hedgehog Proteins / Q000378:metabolism*; D006801:Humans; D011379:Prognosis; D015398:Signal Transduction / Q000187:drug effects*; D013274:Stomach Neoplasms / Q000175:diagnosis* / Q000188:drug therapy* / Q000378:metabolism
chemical_list: D000970:Antineoplastic Agents; D053823:Hedgehog Proteins